Philips shares slump as FDA says sleep product may overheat

Phillips shares fell sharply Wednesday as the Food and Drug Administration said there's an emerging safety issue involving its product for sleep apnea.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.